Mogrify has collected $17m in a second series A tranche led by Parkwalk Advisors to bring the round’s total to $33m.

Athenex will pay $70m upfront and up to $115m in milestone payments to acquire Kuur Therapeutics, providing exits to Baylor College and IP Group.

NeoGenomics has exercised its option to buy Inivata, a precision cancer diagnostics company that was formed to exploit Cambridge and CRUK research seven years ago.

Solidia Technologies, Kelun Biotech and Doer Biologics all raised more than $70m while Sony added cash to a round valuing Discord at $7bn.

Oxford University Innovation has revealed it launched 37 new companies between April 2020 and March 2021, its best run yet.

Dexxon, SoftBank and Sumitomo Dainippon-backed medical company builder Roivant Sciences will get a public listing through the transaction.

Nikon contributed to a $270m round valuing the DNA sequencing eqiupment producer at $3.4bn as it prepares to pursue a public listing.

The Virgin-backed online pharmacy services provider was valued above $1bn in a round that boosted its overall funding to $570m.

The Taiho and UPMC-backed cancer biotherapeutics developer priced its shares in the middle of their range in its initial public offering.